A Message from the Founding Director

Half a century ago, the quantum revolution gave birth to the biomolecular and computer revolutions via the transistor, laser, x-ray crystallography, and the theory of molecular bonds. The twenty-first century will be typified by the synergy of all three revolutions. In the era of molecular medicine, a translational research scientist, who attempts to bridge the gap between basic and clinical science, should have working knowledge of all these three areas. Significant breakthroughs will require a broader view of reality, and, therefore, barriers that have been created due to specialization should be broken. Translational medicine should be able to promote the synthesis of basic knowledge and develop meaningful hypotheses for clinical testing.

In AMPL we pursue cross-disciplinary ideas and deal with high-risk projects that encourage a new, holistic approach to Oral Medicine. We integrate clinical, scientific, and technological excellence to introduce simple, cost-effective, and efficient clinical practices and products. We are also committed to a training program that fosters cooperation between clinicians and biomedical scientists.

I believe the progress of our work should be measured by our ability to transform ideas into action. On the other hand, the success of our work should be measured by our achievement to move our research closer to clinical testing. This is what I call excellence!

Our continued success depends on the alliances we have forged andthe new relationships we hope to create.

Dr. Nikos Soukos